{"component": "definition", "props": {"groups": [{"size": 7, "samples": [{"hash": "hQSgCw0rCAX", "uri": "https://assets.ctfassets.net/13yu1u3hrn9u/BauT3EYh2Ol672FjTbJP7/c8597bf9d5e7f22851d2c51a9dce098c/Policy_on_Materiality_of_Events.pdf", "label": "assets.ctfassets.net", "score": 11.3508529663, "published": false}, {"hash": "hQSgCw0rCAX", "uri": "https://assets.ctfassets.net/13yu1u3hrn9u/38N1JPlXIGCVKrG56XyeI2/425feccd72d537bcf8813a816b4e25a5/Policy_on_Materiality_of_Events.pdf", "label": "assets.ctfassets.net", "score": 6.6762490273, "published": false}, {"hash": "ha4P0J29NRR", "uri": "https://assets.ctfassets.net/oe48y40ukei6/2tKCT8d3e1SAyJp565Fw4x/cdd99bc4f051c3230bf2f92d95f8e278/Policy_for_determination_of_materiality_of_events.pdf", "label": "assets.ctfassets.net", "score": 5.0924024582, "published": false}], "snippet": "means launch of new brands or new product categories and shall not include launch of new variants in existing brand or product categories", "snippet_links": [{"key": "product-categories", "type": "definition", "offset": [34, 52]}], "hash": "720ebdc4e293e3618af608e254196d1c", "id": 1}, {"size": 6, "samples": [{"hash": "ktvQwhyYKTF", "uri": "/contracts/ktvQwhyYKTF#product-launch", "label": "Distribution and Services Agreement (Vivus Inc)", "score": 18.0, "published": true}, {"hash": "ir1hLb0ctgN", "uri": "https://ir.vivus.com/static-files/b5f087f1-14bc-4ff9-bdfd-30265dae1838", "label": "ir.vivus.com", "score": 9.965092659, "published": false}, {"hash": "iS90QNEpwHB", "uri": "https://ir.vivus.com/static-files/932c1a9c-c65f-479a-867b-6246a0c68bd2", "label": "ir.vivus.com", "score": 8.9233398438, "published": false}], "snippet": "means the date selected by VIVUS after VIVUS obtains FDA approval of the Products and upon which ASD is notified by VIVUS that MUSE may be lawfully available for commercial sale and shipment.", "snippet_links": [{"key": "approval-of", "type": "definition", "offset": [57, 68]}, {"key": "the-products", "type": "clause", "offset": [69, 81]}, {"key": "commercial-sale", "type": "clause", "offset": [162, 177]}], "hash": "dfbd7d46322d8f3ef9cc9f35c15350b0", "id": 2}, {"size": 6, "samples": [{"hash": "lTISGpZTJ3g", "uri": "/contracts/lTISGpZTJ3g#product-launch", "label": "License Agreement (Tracon Pharmaceuticals, Inc.)", "score": 25.9911022186, "published": true}, {"hash": "8v5v51ATDPu", "uri": "/contracts/8v5v51ATDPu#product-launch", "label": "License Agreement (Tracon Pharmaceuticals Inc)", "score": 25.70362854, "published": true}, {"hash": "bI0OCsUBOws", "uri": "/contracts/bI0OCsUBOws#product-launch", "label": "License Agreement (Tracon Pharmaceuticals Inc)", "score": 25.5995883942, "published": true}], "snippet": "means the initial delivery to an end user of a Licensed Product(s) that is subject to, and in accordance with, an NDA Approval for such Licensed Product(s).", "snippet_links": [{"key": "initial-delivery", "type": "definition", "offset": [10, 26]}, {"key": "end-user", "type": "definition", "offset": [33, 41]}, {"key": "subject-to", "type": "definition", "offset": [75, 85]}, {"key": "in-accordance-with", "type": "definition", "offset": [91, 109]}, {"key": "nda-approval", "type": "definition", "offset": [114, 126]}], "hash": "551e12ef77d482c1c26a80aeb6be8b73", "id": 3}, {"size": 5, "samples": [{"hash": "ksat8jBrU0O", "uri": "/contracts/ksat8jBrU0O#product-launch", "label": "Commercial Exploitation Agreement (Indivior PLC)", "score": 34.388092041, "published": true}, {"hash": "1U9MMIzirCN", "uri": "/contracts/1U9MMIzirCN#product-launch", "label": "Commercial Exploitation Agreement (Indivior PLC)", "score": 34.1854896545, "published": true}, {"hash": "hy8kMvrfBr5", "uri": "/contracts/hy8kMvrfBr5#product-launch", "label": "Commercial Exploitation Agreement (Aquestive Therapeutics, Inc.)", "score": 29.5366191864, "published": true}], "snippet": "means the first date that the Products are supplied by RB or its agents to a customer in a country within the Territory, save that for the avoidance of doubt such date shall not be before the date on which the Products have been approved and rated by the relevant Regulatory Authority in that country and RB or its Affiliates has obtained a Health Registration in that country.", "snippet_links": [{"key": "first-date", "type": "definition", "offset": [10, 20]}, {"key": "the-products", "type": "clause", "offset": [26, 38]}, {"key": "within-the-territory", "type": "definition", "offset": [99, 119]}, {"key": "for-the-avoidance-of-doubt", "type": "clause", "offset": [131, 157]}, {"key": "relevant-regulatory-authority", "type": "definition", "offset": [255, 284]}, {"key": "health-registration", "type": "definition", "offset": [341, 360]}], "hash": "90b27a65369523fef688ec465a29bd48", "id": 4}, {"size": 5, "samples": [{"hash": "4j6Lo46RAGE", "uri": "/contracts/4j6Lo46RAGE#product-launch", "label": "License and Commercialization Agreement (Petros Pharmaceuticals, Inc.)", "score": 31.8035583496, "published": true}, {"hash": "8drv7SxN0cJ", "uri": "/contracts/8drv7SxN0cJ#product-launch", "label": "License and Commercialization Agreement (Vivus Inc)", "score": 27.8555774689, "published": true}, {"hash": "e9mZ0iJv6eZ", "uri": "http://ir.vivus.com/static-files/dbf4db6c-1017-42bf-9c16-ce2f49823125", "label": "ir.vivus.com", "score": 10.1704311371, "published": false}], "snippet": "means, on a country-by-country basis, the first commercial sale of the Product in a country by Licensee or its Affiliate or sublicensee after the Effective Date to an unrelated Third Party in a bona fide arms-length transaction for use, consumption, or commercial distribution in the Field in the Licensee Territory, excluding any transfer of Product for research, test marketing, clinical trial purposes, compassionate use, or named patient arrangements.", "snippet_links": [{"key": "sale-of-the-product", "type": "definition", "offset": [59, 78]}, {"key": "by-licensee", "type": "clause", "offset": [92, 103]}, {"key": "after-the-effective-date", "type": "clause", "offset": [136, 160]}, {"key": "unrelated-third-party", "type": "definition", "offset": [167, 188]}, {"key": "bona-fide", "type": "definition", "offset": [194, 203]}, {"key": "commercial-distribution", "type": "clause", "offset": [253, 276]}, {"key": "in-the-field", "type": "clause", "offset": [277, 289]}, {"key": "in-the-licensee-territory", "type": "clause", "offset": [290, 315]}, {"key": "transfer-of-product", "type": "clause", "offset": [331, 350]}, {"key": "for-research", "type": "clause", "offset": [351, 363]}, {"key": "test-marketing", "type": "clause", "offset": [365, 379]}, {"key": "clinical-trial", "type": "definition", "offset": [381, 395]}, {"key": "compassionate-use", "type": "definition", "offset": [406, 423]}], "hash": "d186a6d01c0fe921b7cfcb574d6e3d69", "id": 5}, {"size": 5, "samples": [{"hash": "djwaDZqe0O", "uri": "/contracts/djwaDZqe0O#product-launch", "label": "Instrument, Assay Development and License Agreement (Aurora Biosciences Corp)", "score": 18.0, "published": true}, {"hash": "4Vdk86Jracu", "uri": "/contracts/4Vdk86Jracu#product-launch", "label": "Instrument, Assay Development and License Agreement (Aurora Biosciences Corp)", "score": 18.0, "published": true}], "snippet": "means the first commercial sale of a product.", "snippet_links": [{"key": "sale-of", "type": "clause", "offset": [27, 34]}], "hash": "8d73808dd45fe7fa31f6aec57a4eeaa3", "id": 6}, {"size": 4, "samples": [{"hash": "iJhxBH9VHf3", "uri": "/contracts/iJhxBH9VHf3#product-launch", "label": "Research Collaboration and License Agreement (Ribozyme Pharmaceuticals Inc)", "score": 18.0, "published": true}, {"hash": "9Kj0sWcduFH", "uri": "/contracts/9Kj0sWcduFH#product-launch", "label": "Research Collaboration and License Agreement (Ribozyme Pharmaceuticals Inc)", "score": 18.0, "published": true}, {"hash": "68FzCPYrxdK", "uri": "/contracts/68FzCPYrxdK#product-launch", "label": "Research Collaboration and License Agreement (Ribozyme Pharmaceuticals Inc)", "score": 18.0, "published": true}], "snippet": "means the First Commercial Sale of a Ribozyme Product in a particular territory.", "snippet_links": [{"key": "sale-of", "type": "clause", "offset": [27, 34]}, {"key": "ribozyme-product", "type": "definition", "offset": [37, 53]}], "hash": "c8e3bbfe0649f04b36d6fa2dd4e33f02", "id": 7}, {"size": 4, "samples": [{"hash": "dKYz831YrUT", "uri": "/contracts/dKYz831YrUT#product-launch", "label": "License Agreement", "score": 28.6108970642, "published": true}, {"hash": "iixHlPLCDA", "uri": "/contracts/iixHlPLCDA#product-launch", "label": "License Agreement (Senesco Technologies Inc)", "score": 20.0, "published": true}, {"hash": "giaoEIdibR2", "uri": "/contracts/giaoEIdibR2#product-launch", "label": "License Agreement (Senesco Technologies Inc)", "score": 20.0, "published": true}], "snippet": "first commercial sale to a third party of the first Product to be commercialized.", "snippet_links": [{"key": "party-of-the", "type": "clause", "offset": [33, 45]}, {"key": "first-product", "type": "clause", "offset": [46, 59]}], "hash": "406c95606d846ad6deb2c068c3a08be5", "id": 8}, {"size": 4, "samples": [{"hash": "j4PwtV2PsR", "uri": "/contracts/j4PwtV2PsR#product-launch", "label": "Research Agreement (Vertex Pharmaceuticals Inc / Ma)", "score": 18.0, "published": true}, {"hash": "jwqhIj8ZhQ3", "uri": "https://investors.vrtx.com/static-files/4ee095e7-26ff-46e6-93d2-39dfab837f8d", "label": "investors.vrtx.com", "score": 7.9650921822, "published": false}], "snippet": "means, with respect to a particular Drug Product, the First Commercial Sale of that Drug Product.", "snippet_links": [{"key": "with-respect-to", "type": "clause", "offset": [7, 22]}, {"key": "drug-product", "type": "definition", "offset": [36, 48]}, {"key": "sale-of", "type": "clause", "offset": [71, 78]}], "hash": "25e7683610cf8e83c1c37c62d48f4dff", "id": 9}, {"size": 3, "samples": [{"hash": "36ASD51TKu1", "uri": "/contracts/36ASD51TKu1#product-launch", "label": "Collaboration Agreement", "score": 24.8453121185, "published": true}, {"hash": "1EQSIT8bBY7", "uri": "/contracts/1EQSIT8bBY7#product-launch", "label": "Collaboration Agreement", "score": 23.9295005798, "published": true}, {"hash": "4ImzFaNdxBN", "uri": "/contracts/4ImzFaNdxBN#product-launch", "label": "Collaboration Agreement (Amylin Pharmaceuticals Inc)", "score": 18.0, "published": true}], "snippet": "means the date on which Product is first shipped in commercial quantities by a Party, its Affiliate or Sublicensee for commercial sale to Third Persons in the Territory (not Affiliates or Sublicensees) following Marketing Approval of Product, including, if applicable, any necessary Pricing Approval.", "snippet_links": [{"key": "commercial-quantities", "type": "definition", "offset": [52, 73]}, {"key": "by-a-party", "type": "clause", "offset": [74, 84]}, {"key": "commercial-sale", "type": "clause", "offset": [119, 134]}, {"key": "third-persons", "type": "clause", "offset": [138, 151]}, {"key": "in-the-territory", "type": "clause", "offset": [152, 168]}, {"key": "approval-of-product", "type": "clause", "offset": [222, 241]}, {"key": "if-applicable", "type": "clause", "offset": [254, 267]}, {"key": "pricing-approval", "type": "definition", "offset": [283, 299]}], "hash": "a13dac4b84e9f0be4e66f3fa022a11eb", "id": 10}], "next_curs": "ClsSVWoVc35sYXdpbnNpZGVyY29udHJhY3RzcjcLEhpEZWZpbml0aW9uU25pcHBldEdyb3VwX3Y1NiIXcHJvZHVjdC1sYXVuY2gjMDAwMDAwMGEMogECZW4YACAA", "definition": {"size": 120, "snippet": "means launch of new brands or new product categories and shall not include launch of new variants in existing brand or product categories", "title": "Product Launch", "id": "product-launch", "examples": ["Following a <strong>Product Launch</strong>, Company shall make available to each Person who desires to open a related Account an Account Application.", "Company shall establish and maintain a risk management program designed to ensure compliance with Applicable Law and any other Bank requirements provided in the Program Guidelines in the performance of Company\u2019s obligations under this Agreement, including any obligations set forth in a Program Schedule or Program Documents (\u201cRisk Management Program\u201d), which shall be subject to Bank\u2019s review and approval prior to <strong>Product Launch</strong>.", "Bank shall determine, in its sole good faith discretion, whether the conditions for the <strong>Product Launch</strong> have been satisfied."], "related": [["launch", "Launch", "Launch"], ["commercial-launch", "Commercial Launch", "Commercial Launch"], ["product-labeling", "Product Labeling", "Product Labeling"], ["collaboration-product", "Collaboration Product", "Collaboration Product"], ["licensed-product", "Licensed Product", "Licensed Product"]], "related_snippets": [], "updated": "2026-05-03T04:25:59+00:00"}, "json": true, "cursor": ""}}